文献速递白血病MDS 与骨髓增殖性肿瘤造血干细胞移植与细胞治疗

DDX41相关髓系肿瘤易感性

DDX41-associated susceptibility to myeloid neoplasms.
PubMed 文献 · Blood · 2023-01-01

综述DDX41胚系变异与髓系肿瘤易感性的关系。约3%的髓系肿瘤携带DDX41胚系致病变异,呈常染色体显性遗传。肿瘤检测发现截短变异应行胚系检测,因超过95%的此类等位基因为胚系来源。野生型等位基因体细胞突变见于约半数病例,以R525H最常见。

要点

  • 约3%的髓系肿瘤携带DDX41胚系致病变异,呈常染色体显性遗传。
  • 肿瘤检测发现截短变异应行胚系检测,因超过95%的此类等位基因为胚系来源。
  • 野生型DDX41等位基因体细胞突变见于约半数病例,R525H最常见。

核心结论

  • DDX41胚系致病变异以常染色体显性方式遗传, confer髓系肿瘤风险,较少见淋巴系恶性肿瘤,在髓系肿瘤中估计患病率为3%。
  • 携带者发生髓系肿瘤的年龄较大,与散发疾病相似,挑战了遗传性癌症风险总在年轻时发病的范式。
  • 男女变异频率相同,但男性更常进展为髓系肿瘤,提示性别特异性效应影响髓系白血病发生。

研究设计与样本

  • 综述,未报告系统检索范围。

主要发现

  • 胚系DDX41变异包括截短等位基因(约占全部等位基因的三分之二)、优先位于DEAD-box结构域的错义变异和缺失变异。
  • 肿瘤分子检测发现截短等位基因应行胚系遗传检测,因为超过95%的此类等位基因为胚系来源。
  • 野生型DDX41等位基因的体细胞突变发生于约半数携带胚系DDX41等位基因的髓系肿瘤,通常位于编码解旋酶结构域的外显子,最常见为R525H。
  • 携带胚系DDX41致病变异的个体接受野生型供者异基因造血细胞移植后,发生急性严重移植物抗宿主病的比例高于其他人群,除非接受移植后环磷酰胺。
  • 某些变异在特定人群中常见。

临床怎么用

  • 肿瘤分子检测发现截短DDX41等位基因应提示胚系遗传检测,因为超过95%的此类等位基因为胚系来源。
  • 作者指出,携带胚系DDX41致病变异的个体接受野生型供者异基因造血细胞移植后,发生急性严重移植物抗宿主病多于其他人群,除非接受移植后环磷酰胺。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Deleterious germ line DDX41 variants confer risk for myeloid neoplasms (MNs) and less frequently for lymphoid malignancies, with autosomal dominant inheritance and an estimated prevalence of 3% among MNs. Germ line DDX41 variants include truncating alleles that comprise about two-thirds of all alleles, missense variants located preferentially within the DEAD-box domain, and deletion variants. The identification of a truncating allele on tumor-based molecular profiling should prompt germ line genetic testing because >95% of such alleles are germ line. Somatic mutation of the wild-type DDX41 allele occurs in about half of MNs with germ line DDX41 alleles, typically in exons encoding the helicase domain and most frequently as R525H. Several aspects of deleterious germ line DDX41 alleles are noteworthy: (1) certain variants are common in particular populations, (2) MNs develop at older ages typical of de novo disease, challenging the paradigm that inherited cancer risk always causes disease in young people, (3) despite equal frequencies of these variants in men and women, men progress to MNs more frequently, suggesting a gender-specific effect on myeloid leukemogenesis, and (4) individuals with deleterious germ line DDX41 variants develop acute severe graft-versus-host disease after allogeneic hematopoietic cell transplantation with wild-type donors more than others unless they receive posttransplant cyclophosphamide, suggesting a proinflammatory milieu that stimulates donor-derived T cells. Biochemical studies and animal models have identified DDX41's ability to interact with double-stranded DNA and RNA:DNA hybrids with roles in messenger RNA splicing, ribosomal RNAs or small nucleolar RNAs processing, and modulation of innate immunity, disruption of which could promote inflammation and drive tumorigenesis.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Makishima H, Bowman TV, Godley LA, et al. DDX41-associated susceptibility to myeloid neoplasms. Blood. 2023. PMID: 36455200. doi:10.1182/blood.2022017715

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。